ArticleBMC cancer2026

Predicting response to neoadjuvant hormonal therapy and prognostic outcomes in high-risk prostate cancer using MRI-based radiomics.

Hai Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.